Bisphosphonates inactivate human EGFRs to exert antitumor actions

Tony Yuen(Icahn School of Medicine at Mount Sinai), Mone Zaidi(Icahn School of Medicine at Mount Sinai), Shiraz Mujtaba(City University of New York), Yathin Latif(Icahn School of Medicine at Mount Sinai), Shozeb Haider(University College London), Jaya Sangodkar(Pediatrics and Genetics), Jack Bailey(Icahn School of Medicine at Mount Sinai), Agnes Stachnik(Icahn School of Medicine at Mount Sinai), Goutham Narla(Pediatrics and Genetics), Terry F. Davies(University of Minnesota System), Graziana Colaianni(University of Bari Aldo Moro), Yogesh K. Gupta(The University of Texas at San Antonio Health Science Center), Yaoting Ji(Wuhan University), Zhuan Bian(Wuhan University), Jameel Iqbal(DaVita Clinical Research (United States)), Aneel K. Aggarwal(Icahn School of Medicine at Mount Sinai), Se‐Min Kim(Icahn School of Medicine at Mount Sinai), Alberta Zallone(University of Bari Aldo Moro), Peng Liu(Shenyang Pharmaceutical University), Jianhua Li(Guangdong Medical College), Ling-Ling Zhu(Icahn School of Medicine at Mount Sinai), Ping Lü(Cornerstone University), Maria I. New(Unknown), Li Sun(Wuhan University), Miriam Sgobba(University College London), Solomon Epstein, Sudeh Izadmehr(Icahn School of Medicine at Mount Sinai)
Proceedings of the National Academy of Sciences
December 1, 2014
Cited by 60


Related Papers